Literature DB >> 15353058

Cardiology.

Tom Fahey1, Knut Schroeder.   

Abstract

This article describes recent developments in cardiology and cardiovascular disease that are likely to be relevant to primary healthcare professionals and their patients. The following subject areas are covered: Primary prevention: recent developments in pharmaco-logical interventions, drug interactions, and drugs that are likely to cause harm; cardiovascular risk estimation and shared decision making with patients; and new developments in 24-hour ambulatory blood pressure monitoring. Secondary prevention: new models of care, including nurse-led care for the provision of hypertension and secondary prevention clinics; new drugs for the treatment of angina and myocardial infarction; ambulatory electrocardiography for the diagnosis of arrhythmias in primary care; and new developments in the treatment of atrial fibrillation - direct thrombin inhibitors and implantable devices. Tertiary prevention: recent developments in cardiac rehabilitation; recent evidence concerning revascularisation procedures and appropriateness criteria for referral; and implantable defibrillators.

Entities:  

Mesh:

Year:  2004        PMID: 15353058      PMCID: PMC1326073     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  52 in total

1.  Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey.

Authors:  N Steel
Journal:  BMJ       Date:  2000-05-27

2.  Can we pull the plug on warfarin in atrial fibrillation?

Authors:  Freek W A Verheugt
Journal:  Lancet       Date:  2003-11-22       Impact factor: 79.321

3.  Giving aspirin and ibuprofen after myocardial infarction.

Authors:  Stephen E Kimmel; Brian L Strom
Journal:  BMJ       Date:  2003-12-06

4.  Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort study.

Authors:  Jeptha P Curtis; Yongfei Wang; Edward L Portnay; Frederick A Masoudi; Edward P Havranek; Harlan M Krumholz
Journal:  BMJ       Date:  2003-12-06

5.  Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension.

Authors:  Denis L Clement; Marc L De Buyzere; Dirk A De Bacquer; Peter W de Leeuw; Daniel A Duprez; Robert H Fagard; Peter J Gheeraert; Luc H Missault; Jacob J Braun; Roland O Six; Patricia Van Der Niepen; Eoin O'Brien
Journal:  N Engl J Med       Date:  2003-06-12       Impact factor: 91.245

6.  Postmenopausal hormones--therapy for symptoms only.

Authors:  Deborah Grady
Journal:  N Engl J Med       Date:  2003-03-17       Impact factor: 91.245

7.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

8.  Effects of estrogen plus progestin on health-related quality of life.

Authors:  Jennifer Hays; Judith K Ockene; Robert L Brunner; Jane M Kotchen; JoAnn E Manson; Ruth E Patterson; Aaron K Aragaki; Sally A Shumaker; Robert G Brzyski; Andrea Z LaCroix; Iris A Granek; Barbara G Valanis
Journal:  N Engl J Med       Date:  2003-03-17       Impact factor: 91.245

9.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

10.  Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.

Authors:  S Bertil Olsson
Journal:  Lancet       Date:  2003-11-22       Impact factor: 79.321

View more
  1 in total

1.  Nurse-led management of hypertension.

Authors:  Pippa Oakeshott; Sally Kerry; Sally Dean; Franco Cappuccio
Journal:  Br J Gen Pract       Date:  2005-01       Impact factor: 5.386

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.